We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/7/2017 20:19 | Joy, Parob and Slarty all make valid points. As we now know, there are at 9 more national type contracts in the wings, some will take more time than others to get over the line due to territorial infrastructures, like those we learned of today. There were 4 important pieces to the commercial jigsaw exposed today; 1: Potential for wider range of cardiovascular products 2: Finncap produced low to mid 6 figure numbers - this offers the potential for cumulative effect which bring us closer to inflection point - ping effect as I prefer 3: Further insight to SOH's strategic brain. The use of pharmaceutical to get the brand awareness and scientific acceptance of new products with LP-LDL "INTEL INSIDE." 4: Insight to timeline, as in how long it takes from the commercial deal being announced and the potential for products on the retail shelves I can hear whiplash loud and clear Slarty - not sure it's a suitable analogy, I'm not convince "inflection" in right either.....ping is more to my liking. What with the sweet-spot be? A combination of more national announcements incorporating more of the same from Finncap? or Tata products announcement? One or more commercial from £3-6m pa range, or a combination? One things for sure, there are many possibility's, scope for these announcements. For those of us that have been here a while, we just need to hold firm and be patient because we are not far away now. I am sure those of us that appear to have "fallen in love" with OPTI will have the last laugh and welcomed the opportunity to add when we have. Sure, it may not feel this is the case as we fluctuate between 60-80p. Keep in mind, this has usually been below normal market volumes. So imagine how OPTI is going to behave when the market finally wakes up to future potential. You can be thankful for the traders holding us back and allowing the opportunity for more. | elrico | |
26/7/2017 19:44 | F3, in the recent TW interview SOH said "I would hope that on the next occasion we will be able to announce Tata's name in an RNS". Knowing this would need Tata Group approval (not just Tata Chemicals) which takes 6-9 months, I assume that this process is underway as we speak. 7 months have passed since the December Asian MN/Slimbiome RNS. | parob | |
26/7/2017 19:31 | Bobdown2 Regards to your earlier post asking "why visit a troll", all I can say is for me it's like visiting a zoo. I get to see some strange and unusual things and more often than not get a laugh at the absurdity of his imagination. On another note, the rns was another breeze block in the wall. :-) | 1bokke | |
26/7/2017 18:44 | Slartybarfaster, Well, in my opinion, because we are making slow but sure progress... As SOH said today, they pass it over to the pharmaceutical industry ( and their renowned to take ages....) Hey just my humble opinion, it's just a matter of time frames But each RNS builds and builds on their key foundations and it's looking very solid to me. GL love the name by the way! Hitch-hikers guide to the Galaxy . 42 wasn't it? | joyjoy13 | |
26/7/2017 18:33 | I'm hoping we'll hear some more about the Tata link up soon! Products were targeted to be launched in the second half of 2017! That could ignite us! | f3rdinand | |
26/7/2017 18:20 | Why would it joy? We need a few more of these national deals. Imagine another 4 or 5 of these coupled with fincap notes like the one today. The accumulative low to mid 6 figures becomes 1.5 to 3m without the medium to larger deals, 3 to 6m, we then have something in the order of 6 to 9m pretty quickly. Inflection point, whiplash as metallica would have it. | slartybartfaster | |
26/7/2017 17:47 | The business builds and the good old fashioned forward price earnings multiples will be on the horizon. Traders are two a penny, profits on aim are not. Today we were given the regions of the initial revenue involved and if there is a quick take up of the new product then these will be adjusted up at short notice. Some of the posters have called this share spot on so far and let's see it continue.. | bobdown2 | |
26/7/2017 17:19 | Can't believe S/p didn't close higher... But, hey, red letter day... I'm extra special cos I got three ticks down....ha ha. Diamond. Behave! Love this board...facts, fiction and funnies! GLA Better day tomorrow TTFN | joyjoy13 | |
26/7/2017 16:08 | Wish I had got 100,000 more shares now! Like I said the proof of the pudding is in the eating, talking about eating I love nuts JJ13 and have some real big ones if you want to see? Lol. DIAMOND. | diamond fibre | |
26/7/2017 15:15 | owenmo, i fair ok for someone who speaks english as a second language. | incanus | |
26/7/2017 13:43 | Its all jam tomorrow ramping. Until a decent RNS lands we will trade in this range. | monkeywench1 | |
26/7/2017 13:11 | BOBDOWN, I agree to a point. People do visit the troll thread and you could argue mm has one or two followers. Someone needed to take a stand and put certain lies and misinformation right. I just wish it wasnt elrico. His talents are better suited to what he does best, outstanding research and putting them in a document saved in the header. Has anyone provided better info on opti? I and a few other posters think the same, we want elrico to focus on opti not mm because it carries the possibility of his credibility being damaged. Unfortunately, nobody has really took mm to task and to be fair, he has done a real number on mm, which is why he no longer engages with him, or anybody if they post factual contrarian views. And i remember the post elrico mentions. MM stated he had been sat outside elrico home at the time he was have work done to the house. MM discussed the weather and described his dog and commented on the work. A clear attempt to intimidate rather than debate. | incanus | |
26/7/2017 12:59 | And now a phone interview with SOH just out: Milestone for Optiobiotix with first sales in Germany of LPLDL capsules Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive they've reached a significant milestone with first sales in Germany of a new range of cholesterol-lowering capsules containing their breakthrough LP-LDL technology. | parob | |
26/7/2017 12:30 | Where's that taken from Parob? John | 2350220 | |
26/7/2017 12:28 | Optibiotix Health plc: THE INVESTMENT CASE: Finishes with: 'If O’Hara and his team can deliver on his plans that value could be very much enhanced.' | parob | |
26/7/2017 12:05 | Why visit a troll. Surely that defeats the object of banning him from a thread. No one visits a thread where there is only one poster and you have to give them credit for that. | bobdown2 | |
26/7/2017 11:47 | Surprised to see the sells even if they are only small. Today is good news and only the beginning of real and increasing revenues. | rafboy | |
26/7/2017 10:39 | FINNCAP OptiBiotix* (CORP) First launch of LP-LDL capsules in Germany OptioBiotix announced that HLH BioPharma Vertriebs GmbH (HLH) achieved product registration of its LP-LDL capsules and commenced first commercial sales to pharmacies in Germany on 24 July. Whilst revenues are difficult to predict with any certainty, management has indicated that sales revenues are likely to be in low to mid six figures (ie £100-500,000) in the near term. Forecasts remain under review until greater clarity on revenues is gained, yet we are encouraged by the commercial progress the company is making. Alex Pye 020 7220 0554 Mark Brewer 020 7220 0556 Link to Pdf disclaimer (PDF) Disclaimer | elrico | |
26/7/2017 10:30 | Oh flip...think google finance telling porkies again... S/p "live" different than quoted...heyhoe. Will wait till tonight's close GLA | joyjoy13 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions